Business
As part of the planned merger with DiamiR Biosciences, Aptorum Group will expand its board and management team with seasoned executives
NEW YORK, NY, Oct. 09, 2025 (GLOBE NEWSWIRE) -- Aptorum Group Limited (NASDAQ: APM) ("Aptorum Group” or “Aptorum”), a clinical stage biopharmaceutical company dedicated to addressing unmet medical needs, announces the addition of Dr. Laura A. Philips to its board of directors as an independent director at closing of the merger with DiamiR Biosciences Corp. Dr. Philips is the co-founder, President, and Chief Executive Officer of Spheryx, Inc., a technology company developing holographic microscop
About this update from Delcath Systems, Inc.
[{"type":"text","content":"NEW YORK, NY, Oct. 09, 2025 (GLOBE NEWSWIRE) -- Aptorum Group Limited (NASDAQ: APM) ("Aptorum Group” or “Aptorum”), a clinical stage biopharmaceutical company dedicated to addressing unmet medical needs, announces the addition of Dr. Laura A. Philips to its board of directors as an independent director at closing of the merger with DiamiR Biosciences Corp.","length":363,"tagName":"p"},{"type":"text","content":"Dr. Philips is the co-founder, President, and Chief Executive Officer of Spheryx, Inc., a technology company developing holographic microscopic techniques for a broad range of applications in areas including the pharmaceutical industry, semiconductor manufacturing, cosmetics, consumer products, quality assurance, and process control. In addition to co-founding Spheryx in 2014, Dr. Philips has served on the Boards of Directors of multiple private and public life sciences companies, including WellGen, Inc., Delcath Systems, and China Yongxin Pharmaceuticals. From 2003-2006, Dr. Philips was COO and Chief Financial Officer at NexGenix Pharmaceuticals. She held a variety of executive positions at Corning Incorporated from 1997-2002. Dr. Philips served in the Clinton Administration both as a Fellow in the White House Office of Science and Technology Policy and as a Presidential Appointee in the position of Senior Policy Advisor to Secretary Ronald Brown in the Department of Commerce. Dr. Philips holds a Ph.D. in Chemistry from the University of California, Berkeley, and an MBA from Cornell University, and was on the Faculty of Cornell University in the Department of Chemistry from 1987-1993.","length":1204,"tagName":"p"},{"type":"text","content":"“We are really excited to welcome Laura to the team,” said Mr. Ian Huen, CEO and Executive Director of Aptorum Group. “Her scientific and business expertise in growing life sciences companies would strengthen our vision and strategic initiatives focused on becoming a commercial entity addressing aging related diseases.”","length":321,"tagName":"p"},{"type":"text","content":"Dr. Philips commented: “I look forward to working with the joint Aptorum and DiamiR team. I have been following DiamiR’s story since the company’s inception and am a strong believer in its mission to develop and commercialize minimally invasive tests for early detection and monitoring of Alzheimer’s and other br...